Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huangshi Shixing Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and chemical intermediates. Founded in 1953 and based in Huangshi, Hubei Province, the company has established itself as a significant global supplier of antiviral agents, including acyclovir, ganciclovir, and valacyclovir. Their product portfolio also extends to cardiovascular medications and other therapeutic categories. The company operates GMP-compliant facilities and exports its products to numerous international markets, serving as a key partner in the global pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huangshi Shixing Pharmaceutical.